BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.70 USD
-0.05 (-0.65%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $7.71 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BCRX 7.70 -0.05(-0.65%)
Will BCRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BCRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCRX
Are Options Traders Betting on a Big Move in BCRX Stock?
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
Other News for BCRX
Is BCRX poised for a decline? Lower Bollinger Band Walk shows up after gaining 0.65%
BCRX forms Lower Bollinger Band Walk on September 15
BCRX forms Bollinger Band Squeeze on September 12
Is BCRX lining up for a decline? Death Cross shows up after climbing 0.75%
Is BCRX gaining bearish strength? Stochastic Reached Oversold shows up after dropping 0.87%